| Income Statement |
| Operating Expenses | 68.25M |
|
| Research and Development Expense | 49.28M |
| Selling, General and Administrative Expense | 18.97M |
| Operating Income | -68.25M |
| Interest Expense | 3.09M |
| Net Income | -69.77M |
| Net Income Common Stock | -69.77M |
| Net Income Common Stock (USD) | -69.77M |
| Consolidated Income | -69.77M |
| Earnings per Basic Share | -0.72 |
| Earnings per Basic Share (USD) | -0.72 |
| Earnings per Diluted Share | -0.72 |
| Earning Before Interest & Taxes (EBIT) | -66.68M |
| Earning Before Interest & Taxes (USD) | -66.68M |
| Weighted Average Shares | 96.86M |
| Weighted Average Shares Diluted | 96.86M |
| Balance Sheet |
| Cash and Equivalents | 187.06M |
| Cash and Equivalents (USD) | 187.06M |
| Investments | 9.97M |
| Investments Current | 9.97M |
| Current Assets | 200.81M |
| Property, Plant & Equipment Net | 46.70M |
| Total Assets | 252.45M |
| Debt Current | 4.04M |
| Total Debt | 111.98M |
| Current Liabilities | 38.41M |
| Debt Non-Current | 107.94M |
| Total Liabilities | 146.80M |
| Accumulated Retained Earnings (Deficit) | -1.33B |
| Accumulated Other Comprehensive Income | 5.98M |
| Shareholders Equity | 105.65M |
| Shareholders Equity (USD) | 105.65M |
| Assets Non-Current | 51.64M |
| Total Debt (USD) | 111.98M |
| Liabilities Non-Current | 108.39M |
| Trade and Non-Trade Payables | 4.26M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.75M |
| Net Cash Flow from Financing | 800.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.66M |
| Capital Expenditure | -6.00K |
| Issuance (Purchase) of Equity Shares | 1.00M |
| Issuance (Repayment) of Debt Securities | -203.00K |
| Net Cash Flow from Investing | 49.99M |
| Net Cash Flow - Investment Acquisitions and Disposals | 50.00M |
| Net Cash Flow from Operations | -75.73M |
| Effect of Exchange Rate Changes on Cash | 1.27M |
| Share Based Compensation | 7.67M |